Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Candini

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2025
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiencyGiorgio Medici, Marianna Tassinari, Manuela Loi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2022
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency DisorderGiorgio Medici, Marianna Tassinari, Giuseppe Galvani, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2025
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiencyGiorgio Medici, Marianna Tassinari, Manuela Loi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2022
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency DisorderGiorgio Medici, Marianna Tassinari, Giuseppe Galvani, et al.
Pageof 2